RANI
Rani Therapeutics Holdings IncKey Statistics
About Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings Inc. is an innovative biotechnology company focused on transforming the delivery of injectable therapeutics with its cutting-edge RaniPill™ technology, facilitating the oral administration of biologics. This proprietary platform is designed to enhance patient adherence and improve treatment outcomes, addressing key unmet needs in the healthcare sector. With a robust and diverse pipeline across various therapeutic areas, Rani Therapeutics is poised to disrupt traditional drug delivery systems while capitalizing on the growing demand for non-invasive alternatives. The company’s strategic partnerships and unwavering commitment to research and development underscore its potential for sustainable growth and significant impact within the pharmaceutical industry.
Fundamentals
| Revenue (TTM) | $1.63M |
| Gross Profit (TTM) | $1.63M |
| EBITDA | $-37.41M |
| Operating Margin | -584.00% |
| Return on Equity | -182.00% |
| Return on Assets | -50.30% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $0.34 |
| Price-to-Book | 2.53 |
| Price-to-Sales (TTM) | 50.75 |
| EV/Revenue | 23.31 |
| EV/EBITDA | -1.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 42.10% |
| Shares Outstanding | $99.72M |
| Float | $64.32M |
| % Insiders | 5.61% |
| % Institutions | 49.62% |